Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease
Clinical trial NCT00806676 · COMPLETED
Trial details
- NCT number
- NCT00806676
- Sponsor
- Johns Hopkins University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2015-08-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.